(EU) New EU Protocol Aims to Improve Clinical Trial Transparency – TheScientist (Sophie Fessl | February 2022)
The results of clinical trials that aren’t published are a problem. It’s wasteful and inefficient because down the track researchers/clinicians might feel the need to replicate the work to determine if the intervention is safe and efficacious. It is dangerous because subsequently, patients and clinicians might try using the intervention not knowing what the side-effects might be, the risks and whether it will help. It is disrespectful to the people who participated in the research because they will not get to see how their participation ended in results. For these reasons, the EU should be congratulated for introducing this protocol. It is worth noting however, that the US has had law in this regard, which highlights that merely having a regulatory provision means little, unless you enforce it. We are hopeful the EU will enforce this new positive protocol. We have included links to six related items.